Kisha Mitchell-Richards

467 total citations
13 papers, 343 citations indexed

About

Kisha Mitchell-Richards is a scholar working on Pharmacology, Genetics and Hepatology. According to data from OpenAlex, Kisha Mitchell-Richards has authored 13 papers receiving a total of 343 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Pharmacology, 4 papers in Genetics and 4 papers in Hepatology. Recurrent topics in Kisha Mitchell-Richards's work include Inflammatory mediators and NSAID effects (5 papers), Estrogen and related hormone effects (4 papers) and Liver Disease and Transplantation (2 papers). Kisha Mitchell-Richards is often cited by papers focused on Inflammatory mediators and NSAID effects (5 papers), Estrogen and related hormone effects (4 papers) and Liver Disease and Transplantation (2 papers). Kisha Mitchell-Richards collaborates with scholars based in United States, Thailand and Australia. Kisha Mitchell-Richards's co-authors include Michael H. Nathanson, Meenakshisundaram Ananthanarayanan, Carlo Spirlı̀, Marie E. Robert, Jittima Weerachayaphorn, Elena Sáez, Mateus T. Guerra, Jesús M. Bañales, Patricia Muñoz-Garrido and Vitoon Saengsirisuwan and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and Gastroenterology.

In The Last Decade

Kisha Mitchell-Richards

13 papers receiving 337 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kisha Mitchell-Richards United States 8 126 108 88 71 62 13 343
Kenji Fukumoto Japan 8 106 0.8× 48 0.4× 72 0.8× 42 0.6× 60 1.0× 18 288
Bénédicte Delire Belgium 8 178 1.4× 54 0.5× 149 1.7× 148 2.1× 66 1.1× 19 443
Takanori Konishi Japan 7 130 1.0× 150 1.4× 96 1.1× 140 2.0× 47 0.8× 28 376
Junliang Pu China 11 243 1.9× 92 0.9× 91 1.0× 68 1.0× 32 0.5× 22 447
Zhen Zhu China 12 268 2.1× 97 0.9× 34 0.4× 49 0.7× 113 1.8× 23 464
Sook In Chung South Korea 11 198 1.6× 46 0.4× 84 1.0× 111 1.6× 54 0.9× 17 377
Yutaka Takigawa Japan 7 167 1.3× 58 0.5× 95 1.1× 51 0.7× 107 1.7× 27 330
Arturo Simoni‐Nieves Mexico 11 141 1.1× 47 0.4× 91 1.0× 47 0.7× 40 0.6× 20 293
M Kitamura Japan 9 176 1.4× 87 0.8× 31 0.4× 56 0.8× 84 1.4× 24 372
Cyrille Gallois France 6 183 1.5× 80 0.7× 125 1.4× 193 2.7× 45 0.7× 6 482

Countries citing papers authored by Kisha Mitchell-Richards

Since Specialization
Citations

This map shows the geographic impact of Kisha Mitchell-Richards's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kisha Mitchell-Richards with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kisha Mitchell-Richards more than expected).

Fields of papers citing papers by Kisha Mitchell-Richards

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kisha Mitchell-Richards. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kisha Mitchell-Richards. The network helps show where Kisha Mitchell-Richards may publish in the future.

Co-authorship network of co-authors of Kisha Mitchell-Richards

This figure shows the co-authorship network connecting the top 25 collaborators of Kisha Mitchell-Richards. A scholar is included among the top collaborators of Kisha Mitchell-Richards based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kisha Mitchell-Richards. Kisha Mitchell-Richards is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Zhang, Bichen, Min‐Dian Li, Yuyang Liu, et al.. (2019). O-GlcNAc transferase suppresses necroptosis and liver fibrosis. JCI Insight. 4(21). 64 indexed citations
2.
Wang, Jiping, Nancy L. Cho, Ann G. Zauber, et al.. (2018). Chemopreventive Efficacy of the Cyclooxygenase-2 (Cox-2) Inhibitor, Celecoxib, Is Predicted by Adenoma Expression of Cox-2 and 15-PGDH. Cancer Epidemiology Biomarkers & Prevention. 27(7). 728–736. 14 indexed citations
3.
Celli, Romulo, et al.. (2018). Network Analysis of Autopsy Diagnoses: Insights into the “Cause of Death” from Unbiased Disease Clustering. Journal of Pathology Informatics. 9(1). 35–35. 1 indexed citations
4.
Vilarinho, Sílvia, E. Zeynep Erson‐Omay, Kisha Mitchell-Richards, et al.. (2017). Exome analysis of the evolutionary path of hepatocellular adenoma-carcinoma transition, vascular invasion and brain dissemination. Journal of Hepatology. 67(1). 186–191. 8 indexed citations
5.
6.
Goodman, Karyn A., Donna Niedzwiecki, Nathan C. Hall, et al.. (2017). Initial results of CALGB 80803 (Alliance): A randomized phase II trial of PET scan-directed combined modality therapy for esophageal cancer.. Journal of Clinical Oncology. 35(4_suppl). 1–1. 41 indexed citations
7.
Khamphaya, Tanaporn, Vitoon Saengsirisuwan, Kisha Mitchell-Richards, et al.. (2017). Nonalcoholic fatty liver disease impairs expression of the type II inositol 1,4,5‐trisphosphate receptor. Hepatology. 67(2). 560–574. 53 indexed citations
8.
Wang, Jiping, Nancy L. Cho, Ann G. Zauber, et al.. (2017). Expression of COX-2 and 15-PGDH in adenomas removed during pretreatment colonoscopy to predict chemopreventive efficacy of the selective COX-2 inhibitor, celecoxib.. Journal of Clinical Oncology. 35(4_suppl). 524–524. 1 indexed citations
9.
Weerachayaphorn, Jittima, Maria Jimena Amaya, Carlo Spirlı̀, et al.. (2015). Nuclear Factor, Erythroid 2-Like 2 Regulates Expression of Type 3 Inositol 1,4,5-Trisphosphate Receptor and Calcium Signaling in Cholangiocytes. Gastroenterology. 149(1). 211–222.e10. 30 indexed citations
10.
Edelman, Martin J., Xiaofei Wang, Lydia Hodgson, et al.. (2014). Abstract CT238: Phase III randomized, placebo controlled trial of COX-2 inhibition in addition to standard chemotherapy for advanced non-small cell lung cancer (NSCLC):CALGB 30801 (Alliance). Cancer Research. 74(19_Supplement). CT238–CT238. 2 indexed citations
11.
Ananthanarayanan, Meenakshisundaram, Jesús M. Bañales, Mateus T. Guerra, et al.. (2014). Post-translational Regulation of the Type III Inositol 1,4,5-Trisphosphate Receptor by miRNA-506. Journal of Biological Chemistry. 290(1). 184–196. 60 indexed citations
12.
Edelman, Martin J., Lydia Hodgson, Ginger L. Milne, et al.. (2014). Baseline Urinary PGE-M Is a Prognostic and Predictive Marker for Cox-2 Inhibition in Addition to Standard Chemotherapy for Advanced Non-Small Cell Lung Cancer (NSCLC): CALGB 30801 (Alliance). International Journal of Radiation Oncology*Biology*Physics. 90(5). S39–S39. 1 indexed citations
13.
Solomon, Daniel, et al.. (2013). Disseminated enteroinvasive aspergillosis in a critically ill patient without severe immunocompromise. Journal of Surgical Case Reports. 2013(11). rjt091–rjt091. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026